Patents by Inventor Wenjuan Wu

Wenjuan Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11371348
    Abstract: The application discloses a pipeline annular self-traveling guide apparatus and a pipeline annular self-traveling guiding method. The pipeline annular self-traveling guide apparatus includes an inner annular groove and an outer annular groove. A first pipeline fixing part is configured on the inner annular groove, a second pipeline fixing part is configured on the outer annular groove, an annular bracket which is configured to rotate freely along a circumferential direction is correspondingly configured between the inner annular groove and the outer annular groove, a pipeline supporting roller group is configured on the annular bracket, and gaps for laying pipelines are reserved between a circumferential surface of the pipeline supporting roller and inner bottom surfaces of the inner annular groove and the outer annular groove.
    Type: Grant
    Filed: July 8, 2021
    Date of Patent: June 28, 2022
    Assignees: CHINA RAILWAY TUNNEL GROUP CO., LTD., CHINA RAILWAY TUNNEL STOCK CO., LTD.
    Inventors: Yanwei Zhang, Xinpeng Hu, Feng Li, Li Huang, Guohong Ren, Dabing Che, Wenjuan Wu, Qingjun Zheng, Wenhuan Cao, Bin Chen, Yukai Luo, Xiaoli Li, Renyu Wen
  • Publication number: 20210332702
    Abstract: The application discloses a pipeline annular self-traveling guide apparatus and a pipeline annular self-traveling guiding method. The pipeline annular self-traveling guide apparatus includes an inner annular groove and an outer annular groove. A first pipeline fixing part is configured on the inner annular groove, a second pipeline fixing part is configured on the outer annular groove, an annular bracket which is configured to rotate freely along a circumferential direction is correspondingly configured between the inner annular groove and the outer annular groove, a pipeline supporting roller group is configured on the annular bracket, and gaps for laying pipelines are reserved between a circumferential surface of the pipeline supporting roller and inner bottom surfaces of the inner annular groove and the outer annular groove.
    Type: Application
    Filed: July 8, 2021
    Publication date: October 28, 2021
    Inventors: Yanwei ZHANG, Xinpeng HU, Feng LI, Li HUANG, Guohong REN, Dabing CHE, Wenjuan WU, Qingjun ZHENG, Wenhuan CAO, Bin CHEN, Yukai LUO, Xiaoli LI, Renyu WEN
  • Publication number: 20200306254
    Abstract: The present invention provides a combination of an ERK1/2 inhibitor compound, 6,6-dimethyl-2-{2-[(1-methyl-1H-pyrazol-5-yl)amino]pyrimidin-4-yl}-5-[2-(morpholin-4-yl) ethyl]-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one, or a pharmaceutically acceptable salt thereof with gemcitabine, or a pharmaceutically acceptable salt thereof preferably hydrochloride, or with gemcitabine, or a pharmaceutically acceptable salt thereof preferably hydrochloride, and nab-paclitaxel, and to methods of using the combination to treat certain disorders, such as pancreatic cancer, including pancreatic ductal adenocarcinoma (PDAC).
    Type: Application
    Filed: June 22, 2017
    Publication date: October 1, 2020
    Inventors: Shripad BHAGWAT, Ramon Velasquez TIU, Wenjuan WU
  • Patent number: 9518124
    Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.
    Type: Grant
    Filed: August 21, 2013
    Date of Patent: December 13, 2016
    Assignee: Genentech, Inc.
    Inventors: Kang Li, Bin-Bing Stephen Zhou, Wenjuan Wu, Sek Chung Fung, Sanjaya Singh
  • Publication number: 20140093889
    Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.
    Type: Application
    Filed: August 21, 2013
    Publication date: April 3, 2014
    Applicant: Genentech, Inc.
    Inventors: Kang Li, Bin-Bing Stephen Zhou, Wenjuan Wu, Sek Chung Fung, Sanjaya Singh
  • Publication number: 20120213785
    Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.
    Type: Application
    Filed: April 23, 2012
    Publication date: August 23, 2012
    Applicant: Genentech, Inc.
    Inventors: Kang Li, Bin-Bing Stephen Zhou, Wenjuan Wu, Sek Chung Fung, Sanjaya Singh
  • Patent number: 8187839
    Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: May 29, 2012
    Assignee: Genentech, Inc.
    Inventors: Kang Li, Bin-Bing Stephen Zhou, Wenjuan Wu, Sek Chung Fung, Sanjaya Singh
  • Publication number: 20110206675
    Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.
    Type: Application
    Filed: February 23, 2011
    Publication date: August 25, 2011
    Applicant: Genentech, Inc.
    Inventors: KANG LI, Bin-Bing Stephen Zhou, Wenjuan Wu, Sek Chung Fung, Sanjaya Singh
  • Patent number: 7915390
    Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: March 29, 2011
    Assignee: Genentech, Inc.
    Inventors: Kang Li, Bin-Bing Stephen Zhou, Wenjuan Wu, Sek Chung Fung, Sanjaya Singh
  • Publication number: 20100111971
    Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.
    Type: Application
    Filed: October 18, 2007
    Publication date: May 6, 2010
    Inventors: Kang Li, Bin-Bing Stephen Zhou, Wenjuan Wu, Sek Chung Fung, Sanjaya Singh
  • Publication number: 20080118520
    Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.
    Type: Application
    Filed: October 18, 2007
    Publication date: May 22, 2008
    Inventors: Kang Li, Bin-Bing Stephen Zhou, Wenjuan Wu, Sek Chung Fung, Sanjaya Singh
  • Patent number: D978312
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: February 14, 2023
    Assignee: FUJIAN OSPRING TECHNOLOGY DEVELOPMENT CO., LTD
    Inventors: KaiQin Xu, GuoHong Ruan, XiaoYun Lin, XinYi Hu, Qin Zheng, Hao Fang, WenJuan Wu